CBD Does Not Protect Against Postmenopausal Bone Loss in Rats
CBD at 5 mg/kg/day failed to prevent bone loss in ovariectomized rats and actually increased bone resorption markers — ruling it out as a standalone osteoporosis treatment while confirming safety.
Quick Facts
What This Study Found
CBD (5 mg/kg/day for 12 weeks) did not prevent OVX-induced trabecular bone loss, increased bone resorption markers versus OVX controls, and showed no significant effect on cannabinoid receptor expression or bone metabolism genes in sham-operated rats.
Key Numbers
CBD 5 mg/kg/day via osmotic pumps for 12 weeks; OVX/CBD trabecular bone decreased similarly to OVX/vehicle; increased bone resorption markers in OVX/CBD vs OVX/vehicle; no Ctsk gene reduction (unlike estradiol).
How They Did This
12-week controlled study with 5 groups of rats (sham/vehicle, sham/CBD, OVX/vehicle, OVX/estradiol, OVX/CBD), using micro-CT, serum bone markers, and gene expression analysis.
Why This Research Matters
CBD is promoted for many conditions including bone health — this well-designed negative result protects consumers from ineffective treatment and redirects research toward more promising approaches.
The Bigger Picture
Negative results are essential for evidence-based medicine — CBD being safe for bones but ineffective at preventing loss means women shouldn't rely on it as an osteoporosis strategy.
What This Study Doesn't Tell Us
Single dose tested (5 mg/kg/day); osmotic pump delivery may not reflect oral bioavailability; rat OVX model may not fully represent human postmenopausal bone loss; 12-week study may miss very long-term effects.
Questions This Raises
- ?Would higher CBD doses show different results?
- ?Could CBD combined with other cannabinoids or standard therapies have synergistic bone effects?
Trust & Context
- Key Stat:
- Evidence Grade:
- Well-controlled preclinical study with multiple outcome measures and appropriate comparators, providing clear negative evidence.
- Study Age:
- Published in 2026, providing important negative evidence for the CBD-bone health claim.
- Original Title:
- Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.
- Published In:
- JBMR plus, 10(2), ziaf197 (2026)
- Authors:
- Chanpaisaeng, Krittikan, Fleet, James C, Rawiwet, Visut, Phonsatta, Natthaporn, Panya, Atikorn, Panupinthu, Nattapon, Charoenphandhu, Narattaphol
- Database ID:
- RTHC-08160
Evidence Hierarchy
Frequently Asked Questions
Can CBD help with osteoporosis?
No — this study found CBD did not prevent bone loss in a menopause model and actually increased some bone breakdown markers. It should not be relied upon as an osteoporosis treatment.
Is CBD at least safe for bones?
CBD was well-tolerated and didn't cause bone problems in rats with normal estrogen levels. It just doesn't protect against the bone loss that occurs after menopause.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08160APA
Chanpaisaeng, Krittikan; Fleet, James C; Rawiwet, Visut; Phonsatta, Natthaporn; Panya, Atikorn; Panupinthu, Nattapon; Charoenphandhu, Narattaphol. (2026). Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.. JBMR plus, 10(2), ziaf197. https://doi.org/10.1093/jbmrpl/ziaf197
MLA
Chanpaisaeng, Krittikan, et al. "Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.." JBMR plus, 2026. https://doi.org/10.1093/jbmrpl/ziaf197
RethinkTHC
RethinkTHC Research Database. "Long-term cannabidiol treatment did not restore bone microst..." RTHC-08160. Retrieved from https://rethinkthc.com/research/chanpaisaeng-2026-longterm-cannabidiol-treatment-did
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.